8.77
Schlusskurs vom Vortag:
$8.66
Offen:
$8.81
24-Stunden-Volumen:
4.35M
Relative Volume:
0.93
Marktkapitalisierung:
$1.58B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$-171.15M
KGV:
-9.1041
EPS:
-0.9633
Netto-Cashflow:
$122.59M
1W Leistung:
-7.00%
1M Leistung:
+12.29%
6M Leistung:
+38.55%
1J Leistung:
+6.95%
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, BTSG, HQY, TEM, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
8.77 | 1.58B | 2.51B | -171.15M | 122.59M | -0.9633 |
|
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-02-26 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Teladoc Health Inc (TDOC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Teladoc Health Inc (TDOC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TDOC|Teladoc Health Inc|Price:8.770|Chg%:+0.115 - TradingKey
Teladoc Health Inc (TDOC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Teladoc Health Inc (TDOC) Institutional Confidence - TradingKey
Teladoc Health Inc (TDOC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Teladoc Health Inc (TDOC) Valuation: PE, PB & Fair Value Analysis - TradingKey
Teladoc Health Inc (TDOC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Teladoc Health Inc (TDOC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AI Tracker: Teladoc launches new virtual care model - Modern Healthcare
TDOC|Teladoc Health Inc|Price:8.775|Chg%:+0.115 - TradingKey
BofA Securities Maintains Teladoc Health(TDOC.US) With Buy Rating, Maintains Target Price $10.5 - Moomoo
Teladoc Health Unveils Outcome-Based Virtual Care Model for Employers and Health Plans - Digital Health News
Teladoc Health, Inc. (TDOC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.76, Implies 13% Downside - TradingView
TDOC, AMWL Stocks Retreat After OpenAI Lets Users Link Medical Records To ChatGPT - Stocktwits
Teladoc, GoodRx shares fall on OpenAI health feature launch - Investing.com
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Teladoc (TDOC) Shares Decline in Afternoon Trading - GuruFocus
Teladoc Health stock trades lower as revenue growth slows and losses persist - Ad-hoc-news.de
Teladoc launches personalized, risk-based virtual care model - TechTarget
Teladoc Health launches new virtual care model with fees at risk - Investing.com
Teladoc Health Introduces Teladoc One To Deliver Connected And Adaptive Virtual Care - Pulse 2.0
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care - GlobeNewswire
Teladoc Health (TDOC) Q2 2024 earnings summary - Quartr
TDOC Maintained by Canaccord Genuity -- Price Target Raised to $11.00 - GuruFocus
Top AI in Mental Health Companies Driving Care - Fortune Business Insights
Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges With Strategic Potential - DirectorsTalk Interviews
Teladoc (TDOC) Gains As Market Dips: What You Should Know - Yahoo Finance
Teladoc Health (NYSE:TDOC): Has the Rebound Gone Too Far? - Kalkine Media
What Sets Teladoc Health (NYSE:TDOC) Apart in Healthcare Tech? - Kalkine Media
Behavioral Patterns of TDOC and Institutional Flows - Stock Traders Daily
Teladoc Health (TDOC) Faces Fresh Growth Concerns, Is It Still Overvalued? - Sahm
Teladoc Health to announce Q2 2026 results on July 29 - scanx.trade
Teladoc Health to Announce Second Quarter 2026 Financial Results - The Manila Times
Teladoc stock hits 52-week high at 9.78 USD By Investing.com - Investing.com Nigeria
Teladoc stock hits 52-week high at 9.78 USD - Investing.com
Top Telemedicine Companies Transforming Virtual Healthcare - Fortune Business Insights
Teladoc Health to Release Q2 Results After Market Close - Stock Titan
The NBPA taps Teladoc Health for a slam dunk way to simplify healthcare on the go - Medical Marketing and Media
Teladoc Health broadens virtual care reach through Walmart platform - MSN
TDOC stock holds steady as Teladoc Health builds on its telehealth base - ad-hoc-news.de
Teladoc Health Inc. (TDOC) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Teladoc (TDOC) Rises Higher Than Market: Key Facts - Yahoo Finance
Teladoc Health (TDOC) Expands Through Walmart And NBPA Deals, Is Fair Value Still Lower? - Yahoo Finance
Russell Index Removal Could Be A Game Changer For Teladoc Health’s (TDOC) Investment Narrative - Yahoo Finance
Teladoc Health (TDOC) Stock May Be 40% Undervalued As Insurance Coverage Expands - Yahoo Finance
Teladoc Health (TDOC) Lands Walmart Partnership As Profitability Push Comes Into Focus - Yahoo Finance
TELADOC HEALTH NAMED THE PREFERRED VIRTUAL CARE PROVIDER OF THE NBPA - EIN News
DoorDash, Bumble, and Teladoc Shares Plummet, What You Need To Know - Yahoo Finance
Teladoc in the Spotlight as Investors Refocus on Company's Walmart Better Care Partnership - Benzinga
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Teladoc Health Inc-Aktie (TDOC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Catapano Joseph Ronald | Chief Accounting Officer |
Jul 02 '26 |
Sale |
9.10 |
653 |
5,942 |
12,267 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):